Reig Jofre has consolidated its stake in Leanbio by increasing its shareholding from 47% to 85%, following the acquisition of shares valued at €3.5 million. The remaining 15% remains in the hands of the founding team and specialised shareholders. This transaction is...
The company currently holds a 24% stake in Leanbio and has expressed its willingness to acquire a majority stake to consolidate it within Reig Jofre’s scope of operations.
